Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin - A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case-Control Study.

Conclusion: BTX-A is an effective and well-tolerated treatment in patients with benign prostatic hyperplasia (BPH) who are candidates of TURP and simultaneously suffer from OAB symptoms. PMID: 32617023 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32617023?dopt=Abstract

Source: Clinical Pharmacology: Advances and Applications - July 4, 2020 Category: Allergy & Immunology Tags: Clin Pharmacol Source Type: research